2 completed, 2 recruiting, 1 not yet recruiting. 5 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 5 | Completed 2, Recruiting 2, Not yet recruiting 1 |
Follow Human Papilloma Virus (HPV): new trials by email Literature Review of Human Papilloma Virus (HPV) trials Research Report on Human Papilloma Virus (HPV)
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Safety and Systemic Exposure of YCANTH (VP-102) in Subjects With Common Warts (Verruca Vulgaris) (COVE-5) VP-102 - Common Warts, Common Warts (Verruca Vulgaris) | Phase 2 | Not yet recruiting | Verrica Pharmaceuticals Inc. | 30 | 2026-10-01 | 2026-10-20 |
| Omission of Postoperative Radiation in HPV-Associated Oropharyngeal Cancer Using ctHPVDNA Surveillance (OPERATION) Active Surveillance With ctHPVDNA (NavDx®) - Squamous Cell Carcinoma, Human Papilloma Virus (HPV) | Phase 2 | Recruiting | Medical University of South Carolina | 36 | 2026-08-12 | 2026-09-14 |
| A Study of the Preliminary Efficacy of DARE-HPV to Treat High-risk Persistent Human Papillomavirus (hrHPV) Lopinavir / ritonavir - Human Papilloma Virus (HPV), High-risk Human Papillomavirus Infection | Phase 2 | Recruiting | Daré Bioscience, Inc. | 118 | 2026-07-17 | 2026-10-29 |
| Furosemide-Digoxin vs. Polidocanol for Cutaneous Warts Intralesional combined furosemide (10 mg/ml) and digoxin (0.25 mg/ml), Intralesional polidocanol 2% - Cutaneous Warts, Human Papilloma Virus (HPV) | Phase 2 | Completed | Benha University | 64 | 2024-09-01 | 2026-01-02 |
| Combination Therapy for Warts: Candida Antigen vs. Topical Keratolytic Salicylic Acid/Lactic Acid Topical Solution, Candida Antigen Intralesional Injection, Candida Antigen and Salicylic Acid/Lactic Acid - Warts, Human Papilloma Virus (HPV) | Phase 2 | Completed | Benha University | 126 | 2023-12-01 | 2026-08-04 |
Warts (2) · Carcinoma, Squamous Cell (1) · Squamous Cell Carcinoma of Head and Neck (1)
DNA Virus Infections (2) · Infections (2) · Papillomavirus Infections (2) · Skin Diseases (2) · Skin Diseases, Infectious (2) · Skin Diseases, Viral (2) · Skin and Connective Tissue Diseases (2) · Tumor Virus Infections (2) · Virus Diseases (2) · Carcinoma (1) · Head and Neck Neoplasms (1) · Neoplasms (1) · Neoplasms by Histologic Type (1) · Neoplasms by Site (1) · Neoplasms, Glandular and Epithelial (1)
Digoxin (1) · Lopinavir (1) · VP-102 (1) · Watchful Waiting (1) · lactic acid, salicylic acid drug combination (1)
Benha University (2) · Daré Bioscience, Inc. (1) · Medical University of South Carolina (1) · Verrica Pharmaceuticals Inc. (1)
United States (3) · Egypt (2)
Andrea Thurman, MD (1) · Bhishamjit Chera, MD (1) · Ghada Shams (1) · Ghada Shams, MD (1)